市场调查报告书
商品编码
1466386
吸烟和尼古丁去除产品市场:按产品和分布 - 全球预测 2024-2030Smoking Cessation & Nicotine De-Addiction Product Market by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers), Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
戒烟和尼古丁去除产品市场规模预计2023年为282.5亿美元,2024年达到308.9亿美元,预计2030年将达到538.7亿美元,复合年增长率为9.65%。
戒烟和戒烟成瘾市场包括各种旨在帮助个人戒烟和克服尼古丁成瘾的产品和服务。大众对吸烟和尼古丁成瘾对健康造成的后果的认识不断提高,正在推动戒烟辅助产品的采用。旨在控制吸烟率的严格法规和政策正在促进市场成长。我们的产品不断创新,包括电子烟和基于应用程式的戒烟支援。然而,严格的监管和可能禁止某些含尼古丁产品可能会阻碍市场成长。戒烟者復吸的可能性很高,这对戒烟辅助产品的有效性提出了持续的挑战。此外,应利用巨量资料分析来制定个人化戒烟计划,以提高成功率。监测生理参数并提供即时支持和回馈的穿戴式装置可以增强戒烟和尼古丁戒烟产品的使用。
主要市场统计 | |
---|---|
基准年[2023] | 282.5亿美元 |
预测年份 [2024] | 308.9亿美元 |
预测年份 [2030] | 538.7亿美元 |
复合年增长率(%) | 9.65% |
越来越多采用电子烟作为戒烟产品
戒烟药物治疗的重点是处方药,透过减少烟瘾和戒断症状来帮助人们戒烟。主要药物包括Varenicline和安非他酮,它们作用于神经节以减少尼古丁的愉悦作用。电子烟以蒸气形式输送尼古丁,而不燃烧烟草。近年来,电子烟在寻求传统吸烟替代品的用户中越来越受欢迎。尼古丁吸入器是一种尼古丁替代疗法(NRT),可以模仿吸烟的行为,同时吸入尼古丁蒸气而不是烟雾。主要好处是它可以减少接触香烟中有害焦油和化学物质的机会。尼古丁替代疗法包括贴片、口香糖、含片、吸入器和喷雾剂,提供可控剂量的尼古丁,不含焦油、一氧化碳和香烟中的其他有害元素,旨在逐渐戒除尼古丁。尼古丁舌下片在舌下溶解,将尼古丁直接输送到血液中。
分销:为了方便和谨慎,顾客转向网路药局
传统上,药局一直是想要快速获得戒烟辅助工具的人的首选。药局贩售各种成药,包括尼古丁贴片、口香糖和含片。顾客更喜欢药局,在那里他们可以从药剂师那里获得个人建议并快速获得产品。医院药房主要为患者提供咨询医疗保健专业人员后开出的某些戒烟辅助药物。网路药局的便利性和自由裁量权正变得越来越有吸引力,特别是在避免亲自购买或实体店选择有限的地区。零售药局通常是大型连锁店或超级市场的一部分,出售各种戒烟辅助工具和各种其他产品。零售药局将广泛分销的便利性与便捷的取得和通常具有竞争力的价格结合起来。
区域洞察
美国和加拿大是美洲戒烟辅助产品的重要市场。美洲地区的特点是,在医疗保健政策和社区支持计划的支持下,消费者对戒烟辅助措施的认识和意愿较高。中东和非洲地区由于不同的法规环境和吸烟文化而面临挑战。严格的广告法规和反吸烟法正在推动欧洲国家对戒烟产品的需求。亚太地区由中国、日本和印度等主要市场组成,消费行为。政府强而有力的反吸烟政策,加上人们对吸烟危害的认识不断提高,促使亚太地区对尼古丁戒烟产品的需求不断增长。
FPNV定位矩阵
FPNV 定位矩阵对于评估戒烟和尼古丁去除产品市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对戒烟和尼古丁去除产品市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.戒烟除尼古丁产品市场规模及预测为何?
2.在戒烟和尼古丁去除产品市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.戒烟和尼古丁去除产品市场的技术趋势和法规结构是什么?
4.戒烟和尼古丁去除产品市场主要供应商的市场占有率是多少?
5. 进入戒烟除尼古丁产品市场的合适型态和策略手段是什么?
[199 Pages Report] The Smoking Cessation & Nicotine De-Addiction Product Market size was estimated at USD 28.25 billion in 2023 and expected to reach USD 30.89 billion in 2024, at a CAGR 9.65% to reach USD 53.87 billion by 2030.
The smoking cessation and nicotine de-addiction market encompasses a variety of products and services designed to help individuals stop smoking and overcome nicotine addiction. Rising public awareness concerning the health hazards posed by smoking and nicotine addiction enhance the adoption of smoking cessation products. Stringent regulations and policies aiming to curb smoking rates contribute to the market growth. Ongoing innovations in product offerings, such as e-cigarettes and app-based support for smoking cessation. However, stringent regulations and the potential banning of certain nicotine-containing products can hamper market growth. The high propensity for relapse among quitters poses a persistent challenge to the efficacy of cessation products. Moreover, developing personalized cessation plans using big data analytics to improve success rates. Wearable devices that monitor physiological parameters to offer real-time support and feedback, enhancing use of smoking cessation and nicotine de-addiction products.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 28.25 billion |
Estimated Year [2024] | USD 30.89 billion |
Forecast Year [2030] | USD 53.87 billion |
CAGR (%) | 9.65% |
Product: Rising adoption of E-cigarettes for smoking cessation
Drug therapy for smoking cessation focuses on prescription medications that aid in quitting smoking by reducing cravings and withdrawal symptoms. Key drugs include varenicline and bupropion working on the neurological level to decrease the pleasurable effects of nicotine. E-cigarettes, or electronic cigarettes, deliver nicotine in a vapor form without burning tobacco. In recent years, e-cigarettes have gained popularity among users seeking alternatives to traditional smoking. Nicotine inhalers are a form of nicotine replacement therapy (NRT) that allow users to mimic the act of smoking while inhaling nicotine vapor, not smoke. The major advantage is the reduction of exposure to the harmful tar and chemicals in cigarettes. Nicotine replacement therapies include patches, gums, lozenges, inhalers, and sprays that are designed to gradually wean smokers off nicotine by supplying controlled, reduced doses of nicotine without tar, carbon monoxide, and other harmful elements found in cigarettes. Nicotine sublingual tablets dissolve under the tongue, delivering nicotine directly into the bloodstream.
Distribution: Customer inclination towards online pharmacies for convenience and discretion
Drug stores are traditionally a prime choice for individuals seeking immediate access to smoking cessation aids. Drug stores offer a wide range of over-the-counter options, including nicotine patches, gum, and lozenges. Customers prefer drug stores for personalized advice from pharmacists and the ability to obtain products quickly. Hospital pharmacies cater primarily to patients prescribed specific cessation aids, often following consultation with healthcare professionals. The convenience and discretion of online pharmacies are increasingly attractive and are especially preferred to avoid in-person purchases or in areas with limited physical pharmacy options. Retail pharmacies, often part of larger chains or supermarkets, offer broad access to smoking cessation products and various other goods. Retail pharmacies combine the convenience of wide distribution with accessibility and often competitive pricing.
Regional Insights
The United States and Canada represent significant markets for smoking cessation products in the Americas. The Americas region is characterized by high consumer awareness and willingness to adopt smoking cessation aids, supported by healthcare policies and community support programs. The EMEA region presents a mixed picture, with EU countries leading in smoking cessation initiatives, while the Middle East and Africa face challenges due to varying regulatory environments and smoking culture. Strict advertising restrictions and smoke-free laws drive the demand for smoking cessation products in European countries. The Asia Pacific region, comprising significant markets such as China, Japan, and India, showcases diverse consumer behavior towards smoking cessation. Robust governmental anti-smoking policies combined with a growing awareness of smoking hazards contribute to the escalating demand for nicotine de-addiction products in the APAC region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Smoking Cessation & Nicotine De-Addiction Product Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Smoking Cessation & Nicotine De-Addiction Product Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Smoking Cessation & Nicotine De-Addiction Product Market, highlighting leading vendors and their innovative profiles. These include 22nd Century Group, Inc., Alkalon A/S, Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Ditch Labs, Dr. Reddy's Laboratories Limited, Enorama Pharma AB, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Imperial Tobacco Company of India Limited, Itaconix, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs, Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Philip Morris International Inc., Pierre Fabre S.A., Rusan Pharma Ltd., Samyang Holdings Corporation, Sparsha Pharma International Pvt. Ltd., and Strides Pharma Science Limited.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Smoking Cessation & Nicotine De-Addiction Product Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Smoking Cessation & Nicotine De-Addiction Product Market?
3. What are the technology trends and regulatory frameworks in the Smoking Cessation & Nicotine De-Addiction Product Market?
4. What is the market share of the leading vendors in the Smoking Cessation & Nicotine De-Addiction Product Market?
5. Which modes and strategic moves are suitable for entering the Smoking Cessation & Nicotine De-Addiction Product Market?